Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Troya Therapeutics ApS
APS
Active
CVR 44032589
Ole Maaløes Vej 3
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2023
5 employees
www.troya-tx.com
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK -2,4M
+140% vs 2024
EBITDA margin
224.9%
-297% vs 2024
Equity ratio
-64.4%
Financial strength
Net profit 2025
DKK -4,6M
-222% vs 2024
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2023
-1M
-100%
2024
-5M
-400%
2025
Key figures
Annual report 2025
Revenue
DKK -2,4M
+140%
EBITDA
DKK -5,4M
-297%
Net profit
DKK -4,6M
-222%
Total assets
DKK 9,9M
+152%
Equity
DKK -6,4M
-264%
Employees
5
—
Company information
Legal name
Troya Therapeutics ApS
CVR number
44032589
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24. april 2023
Share capital
DKK 40.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
Contact
Address
Ole Maaløes Vej 3
Website
www.troya-tx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
-1M
2024
-2M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
-1M
2024
-5M
2025
Income statement
DKK thousands
Item
2023
2024
2025
Revenue
-421
-991
-2.382
Staff expenses
-0
-358
-2.975
EBITDA
-421
-1.350
-5.356
Depreciation & amort.
-0
-0
-0
EBIT
-421
-1.350
-5.356
Net financials
-38
-175
-474
Profit before tax
-459
-1.525
-5.831
Tax
-100
-84
-1.192
Net profit
-359
-1.441
-4.638
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
1.133
3.944
9.932
Equity
-319
-1.760
-6.398
Long-term debt
1.436
5.607
16.092
Short-term debt
16
98
239
Total debt
1.452
5.704
16.331
Financial ratios
5-year trend
EBITDA margin
-535637100.0%
This company
15.8%
Market median
-3390108328% vs market
2023
2025
Equity ratio
-64.4%
This company
38.2%
Market median
-269% vs market
2023
2025
Return on equity
-463832100.0%
This company
18.4%
Market median
-2520826730% vs market
2023
2025
Net profit margin
-463832100.0%
This company
8.1%
Market median
-5726322322% vs market
2023
2025
Asset turnover
-0.24×
This company
1.12×
Market median
-121% vs market
2023
2025
Debt / equity
2.55×
This company
0.62×
Market median
-311% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-04-24 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
SD
Sean Dean Lykke Harwood
Management
Management
2023
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
CG
Christian Grøndahl
Board of Directors
2025
—
—
JJ
Jan Johannes Enghild
Board of Directors
2023
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ulrik Bjerl Nielsen
Individual
33.3%
33.3%
2025
Seandean Lykke Harwood Holding ApS
Company
25.0%
25.0%
2023
EnghildThøgersen Holding ApS
Company
20.0%
20.0%
2023
Austin Wayne Boesch
Individual
10.0%
10.0%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Troya Therapeutics ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Sean Dean Lykke Harwood
Management
0 companies
Christian Grøndahl
Board of Directors
0 companies
Jan Johannes Enghild
Board of Directors
0 companies